Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 1;11(3):e0150045.
doi: 10.1371/journal.pone.0150045. eCollection 2016.

Phenolic Compounds in Extra Virgin Olive Oil Stimulate Human Osteoblastic Cell Proliferation

Affiliations

Phenolic Compounds in Extra Virgin Olive Oil Stimulate Human Osteoblastic Cell Proliferation

Olga García-Martínez et al. PLoS One. .

Abstract

In this study, we aimed to clarify the effects of phenolic compounds and extracts from different extra virgin olive oil (EVOO) varieties obtained from fruits of different ripening stages on osteoblast cells (MG-63) proliferation. Cell proliferation was increased by hydroxytyrosol, luteolin, apigenin, p-coumaric, caffeic, and ferulic acids by approximately 11-16%, as compared with controls that were treated with one vehicle alone, while (+)-pinoresinol, oleuropein, sinapic, vanillic acid and derivative (vanillin) did not affect cell proliferation. All phenolic extracts stimulated MG-63 cell growth, and they induced higher cell proliferation rates than individual compounds. The most effective EVOO phenolic extracts were those obtained from the Picual variety, as they significantly increased cell proliferation by 18-22%. Conversely, Arbequina phenolic extracts increased cell proliferation by 9-13%. A decline in osteoblast proliferation was observed in oils obtained from olive fruits collected at the end of the harvest period, as their total phenolic content decreases at this late stage. Further research on the signaling pathways of olive oil phenolic compounds involved in the processes and their metabolism should be carried out to develop new interventions and adjuvant therapies using EVOO for bone health (i.e.osteoporosis) in adulthood and the elderly.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Effect of EVOO phenolic extracts on the growth of MG-63 cells as determined by MTT.
Cells were treated with various concentrations of EVOO phenolic extract or vehicle alone (control) for 24 h. Data are means, with standard error of the mean shown by vertical bars of three separate experiments and at least every experiment was performed in triplicate. Mean values were significantly different as compared with control groups: *p<0.05, **p<0.01.
Fig 2
Fig 2. Bi-plot (A. Scores and B. Loadings) for the PCA model.
Samples are plotted by selected letters and numbers: Picual RI 0.37 (P1); Picual RI 2.75 (P2); Picual RI 4.67 (P3); Hojiblanca RI 0.51 (H1); Hojiblanca RI 1.78 (H2); Hojiblanca RI 4.44; Arbequina RI 0.48 (A1); Arbequina RI 2.92 (A2); Arbequina RI 3.67 (A3); Picudo RI 0.88 (Pi1); Picudo RI 1.74 (Pi2); Picudo RI 3.84 (Pi3). The capital letters A, B and C correspond with 0.001, 0.0001 and 0.0001% extract concentration in osteoblast culture medium.

Similar articles

Cited by

References

    1. Cashman K. Diet, nutrition and bone health. J Nutr. 2007; 137:2507–2512. - PubMed
    1. Rivas A, Romero A, Mariscal-Arcas M, Monteagudo C, Feriche B, Lorenzo ML et al. Mediterranean diet and bone mineral density in two age groups of women. Int J Food Sci Nutr. 2013; 64:155–161. 10.3109/09637486.2012.718743 - DOI - PubMed
    1. Rivas A and Romero A., Adherence to Mediterranean Diet and bone health. Nutr Hosp. 2014; 29: 989–996. 10.3305/nh.2014.29.5.7332 - DOI - PubMed
    1. Visioli F, Bernardini E, Extra virgin olive oil's polyphenols: biological activities. Curr Pharm. Des. 2011; 17:786–804. - PubMed
    1. Hagiwara K, Goto T, Araki M, Miyazaki H, and Hagiwara H.. Olive polyphenol hydroxytyrosol prevents bone loss. Eur J Pharmacol. 2011; 662:78–84. 10.1016/j.ejphar.2011.04.023 - DOI - PubMed

MeSH terms